Portal de Periódicos da CAPES

A Role for CRH and the Sympathetic Nervous System in Stress‐Induced Immunosuppressiona

1995; Wiley; Volume: 771; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1995.tb44698.x

1749-6632

Elliot Friedman, Michael R. Irwin,

Adrenal Hormones and Disorders

Annals of the New York Academy of SciencesVolume 771, Issue 1 p. 396-418 A Role for CRH and the Sympathetic Nervous System in Stress-Induced Immunosuppressiona ELLIOT M. FRIEDMAN, ELLIOT M. FRIEDMAN Department of Psychiatry San Diego VA Medical Center and University of California San Diego 3350 La Jolla Village Drive San Diego, California 92161Search for more papers by this authorMICHAEL R. IRWIN, MICHAEL R. IRWIN Department of Psychiatry San Diego VA Medical Center and University of California San Diego 3350 La Jolla Village Drive San Diego, California 92161Search for more papers by this author ELLIOT M. FRIEDMAN, ELLIOT M. FRIEDMAN Department of Psychiatry San Diego VA Medical Center and University of California San Diego 3350 La Jolla Village Drive San Diego, California 92161Search for more papers by this authorMICHAEL R. IRWIN, MICHAEL R. IRWIN Department of Psychiatry San Diego VA Medical Center and University of California San Diego 3350 La Jolla Village Drive San Diego, California 92161Search for more papers by this author First published: December 1995 https://doi.org/10.1111/j.1749-6632.1995.tb44698.xCitations: 32 a This work was supported by VA Merit Review and National Institutes of Mental Health Grants (MH-44275-05 and MH-46867-01) to M. Irwin. Additional support was provided in part by a General Clinical Research Center Grant (MO1 RR00827), and the Mental Health Clinical Research Center Grant (MH-30914). Portions of this paper may have been published previously. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1 Riley, V. 1981. Psychoneuroendocrine influences on immunocompetence and neoplasia. Science 212: 1100– 1109. 2 Stein, M., R. C. Schiavi & M. Camerino. 1976. Influence of brain and behavior on the immune system. Science 191: 435– 440. 3 Baybutt, H. N. & F. Holsboer. 1990. Inhibition of macrophage differentiation and function by cortisol. Endocrinol 127: 476– 480. 4 Butler, W. T. & R. D. Rossen. 1973. Effects of corticosteroids on immunity in man. J. Clin. Invest. 52: 2629– 2640. 5 Heilman, D. H., M. R. Gambrill & J. P. Leichner. 1973. The effects of hydrocortisone on the incorporation of tritiated thymidine by human blood lymphocytes cultured with phytohaemagglutinin and pokeweed mitogen. Clin. Exp. Immunol. 15: 203– 212. 6 Keller, S. E., J. M. Weiss, S. J. Schliefer, N. E. Miller & M. Stein. 1983. Stress-induced suppression of immunity in adrenalectomized rats. Science 221: 1301– 1304. 7 Cunnick, J. E., D. T. Lysle, B. J. Kucinski & B. S. Rabin. 1990. Evidence that shock-induced immune suppression is mediated by adrenal hormones and peripheral β-adrenergic receptors. Pharmacol. Biochem. Behav. 36: 645– 651. 8 Flores, C. M., M. C. Hernandez, K. M. Hargreaves & B. M. Bayer. 1990. Restraint stress-induced elevations in plasma corticosterone and β-endorphin are not accompanied by alterations in immune function. J. Neuroimmunol. 28: 219– 225. 9 Friedman, E. M., C. L. Coe & W. B. Ershler. 1991. Time-dependent effects of peer separation on lymphocyte proliferation responses in juvenile squirrel monkeys. Dev. Psychobiol. 24: 159– 173. 10 Jessop, J. J. & B. M. Bayer. 1989. Time-dependent effects of isolation on lymphocyte and adrenocortical activity. J. Neuroimmunol. 23: 143– 147. 11 Mormede, P., R. Dantzer, B. Michaud, K. W. Kelley & M. Le Moal. 1988. Influence of stressor predictability and behavioral control on lymphocyte reactivity, antibody responses and neuroendocrine activation in rats. Physiol. Behav. 43: 577– 583. 12 Nerozzi, D., A. Santoni, G. Bersani, et al. 1989. Reduced natural killer cell activity in major depression: neuroendocrine implications. Psychoneuroendocrinology 14: 295– 301. 13 Keller, S. E., S. J. Schliefer, A. S. Liotta, R. N. Bond, N. Farhoody & M. Stein. 1988. Stress-induced alterations of immunity in hypophysectomized rats. Proc. Natl. Acad. Sci. USA 85: 9297– 9301. 14 Cross, R. J., W. H. Brooks & T. L. Roszman. 1980. Hypothalamic-immune interactions. I. The acute effect of anterior hypothalamic lesions on the immune response. Brain Res. 196: (1): 79– 87. 15 Devi, R. S. & A. Namasivayam. 1991. Modulation of specific immunity by ventral hippocampal formation in albino rats. J. Neuroimmunol. 33: 1– 6. 16 Barneoud, P., P. J. Neveu, S. Vitiello & M. Le Moal. 1987. Functional heterogeneity of the right and left cerebral neocortex in the modulation of the immune system. Physiol. Behav. 41: 525– 530. 17 Laudenslager, M. L., S. M. Ryan, R. C. Drugan, R. L. Hyson & S. F. Maiser. 1983. Coping and immunosuppression: inescapable but not escapable shock suppresses lymphocyte proliferation. Science 221: 568. 18 Coe, C. L., S. G. Wiener, L. T. Rosenberg & S. Levine. 1985. Endocrine and immune responses to separation and maternal loss in nonhuman primates. In The Psychobiology of Attachment. M. Reite & T. Field, Eds.: 163– 199. Academic Press. New York , NY . 19 Ader, R. & N. Cohen. 1991. The influence of conditioning on immune responses. In Psychoneuroimmunology. R. Ader, D. L. Felten & N. Cohen, Eds.: 609– 646. Academic Press. San Diego , CA . 20 Lysle, D. T., J. E. Cunnick, H. Fowler & B. S. Rabin. 1988. Pavlovian conditioning of shock-induced suppression of lymphocyte reactivity: acquisition, extinction, and preexposure effects. Life Sci. 42: 2185– 2194. 21 Felten, D. L., S. Y. Felten, D. L. Bellinger, et al. 1987. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol. Rev. 100: 225– 260. 22 Dunn, A. J. & C. W. Berridge. 1987. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacol. Biochem. Behav. 27: 685– 693. 23 Fisher, L. A., J. Rivier, C. Rivier, J. Spiess, W. W. Vale & M. R. Brown. 1982. CRF: central effects on mean arterial pressure and heart rate in rats. Endocrinology 110: 2222– 2224. 24 Koob, G. F. & F. E. Bloom. 1985. Corticotropin-releasing factor and behavior. Fed. Proc. 44: 259. 25 Rivier, C. & W. Vale. 1983. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 305: 325– 327. 26 Vale, W., J. Spiess, C. Rivier & J. Rivier. 1981. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213: 1394– 1397. 27 Kalin, N. H. 1985. Behavioral effects of ovine corticotropin-releasing factor administered to rhesus monkeys. Fed. Proc. 44: 249– 253. 28 Kalin, N. H., S. E. Shelton, G. W. Kraemer & W. T. McKinney. 1983. Associated endocrine physiological and behavioral changes in rhesus monkeys after intravenous corticotropin-releasing factor administration. Peptides 4: 211– 215. 29 Owens, M. J. & C. B. Nemeroff. 1991. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43: 425– 473. 30 Spadaro, F., C. W. Berridge, H. A. Baldwin & A. J. Dunn. 1990. Corticotropin-releasing factor acts via a third ventricle site to reduce exploratory behavior in rats. Pharmacol. Biochem. Behav. 36: 305– 309. 31 Berridge, C. W. & A. J. Dunn. 1987. A corticotropin-releasing factor antagonist reverses the stress-induced changes in exploratory behavior in mice. Horm. Behav. 21: 393– 401. 32 Rivier, C., J. Rivier & W. Vale. 1982. Inhibition of adrenocorticotropic hormone secretion in the rat by immunoneutralization of corticotropin-releasing factor. Science 218: 377– 379. 33 Bloom, F. E., E. Battenberg, J. Rivier & W. Vale. 1982. Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus. Regul. Pept. 4: 43– 48. 34 Pelletier, G., L. Desy, J. Cote, G. Lefevre, H. Vaudry & F. Labrie. 1982. Immunoelectron microscopic localization of corticotropin-releasing factor in the rat hypothalamus. Neuroendocrinology 35: 402– 404. 35 Rho, J. H. 1987. Neuroendocrine CRF motoneurons: intrahypothalamic axon terminals shown with a new retrograde-lucifer-immuno method. Brain Res. 436: 143– 147. 36 Antoni, F. A., M. Palkovits, G. B. Makara, E. A. Linton, P. J. Lowry & J. Z. Kiss. 1983. Immunoreactive corticotropin-releasing hormone in the hypothalamoinfundibular tract. Neuroendocrinology 36: 415– 423. 37 Liposits, Z., I. Lengvari, S. Vigh, A. V. Schally & B. Flerko. 1983. Immunohistological detection of degenerating CRF-immunoreactive nerve fibers in the median eminence after lesion of paraventricular nucleus of the rat. Peptides 4: 941– 953. 38 Cassell, M. D. & T. S. Gray. 1989. Morphology of peptide-immunoreactive neurons in the rat central nucleus of amygdala. J. Comp. Neurol. 281: 320– 333. 39 Gray, T. S. & D. J. Magnuson. 1987. Neuropeptide neuronal efferents from the bed nucleus of the stria terminalis and central amygdaloid nucleus to the dorsal vagal complex in the rat. J. Comp. Neurol. 262: 365– 374. 40 Chappell., P. B., M. A. Smith, C. D. Kilts, et al. 1986. Alterations in corticotropin-releasing factor like immunoreactivity in discrete rat brain regions after acute and chronic stress. J. Neurosci. 6: 2908– 2914. 41 Haas, D. A. & S. R. George. 1988. Single or repeated mild stress increases synthesis and release of hypothalamic corticotropin-releasing factor. Brain Res. 461: 230– 237. 42 Harbuz, M. S. & S. L. Lightman. 1989. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J. Endocrinol. 122: 705– 711. 43 Imaki, T., J. Nahan, C. Rivier, P. E. Sawchenko & W. Vale. 1991. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J. Neurosci. 11: 585– 599. 44 Sato, T., M. Sato, J. Shinsako & M. F. Dallman. 1975. Corticosterone-induced changes in hypothalamic corticotropin-releasing factor (CRF) content after stress. Endocrinology 97: 265– 274. 45 Plotsky, P. M. & W. Vale. 1984. Hemorrhage-induced secretion of corticotropin-releasing factor-like immunoreactivity into the rat hypophysial portal circulation and its inhibition by glucocorticoids. Endocrinology 114: 164– 169. 46 Britton, K. T., G. Lee, R. Dana, S. C. Risch & G. F. Koob. 1986. Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone. Life Sci. 39: 1281– 1286. 47 Dunn, A. J. & C. W. Berridge. 1990. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses Brain Res. Rev. 15: 71– 100. 48 Ehlers, C. L., S. J. Henriksen, M. Wang, J. Rivier, W. W. Vale & F. E. Bloom. 1983. CRF produces increases in brain excitability and convulsive seizures in rats. Brain Res. 332: 336. 49 Sutton, R. E., G. F. Koob, M. Le Moal, J. Rivier & W. Vale. 1982. Corticotropin releasing factor produces behavioral activation in rats. Nature 297: 331– 333. 50 Britton, K. T., G. Lee, W. Vale, J. Rivier & G. F. Koob. 1986. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat. Brain Res. 369: 303– 306. 51 Britton, K. T., J. Morgan, J. Rivier, W. Vale & G. F. Koob. 1985. Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test. Psychopharmacology 86: 170– 174. 52 Valentino, R. J., S. L. Foote & G. Aston-Jones. 1983. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res. 270: 363– 367. 53 Butler, P. D., J. M. Weiss, J. C. Stout & C. B. Nemeroff. 1990. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J. Neurosci. 10: 176– 183. 54 Brown, M. R. & L. A. Fisher. 1985. Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems. Fed. Proc. 44: 243– 248. 55 Fisher, L. A. 1989. Central autonomic modulation of cardiac baro-reflex by corticotropin-releasing factor. Am. J. Physiol. 256: H949– H955. 56 Brown, M. R., L. A. Fisher, V. Webb, W. W. Vale & J. E. Rivier. 1985. Corticotropin-releasing factor: a physiologic regulator of adrenal epinephrine secretion. Psychiatry Res. 328: 355– 357. 57 Shavit, Y., J. W. Lewis, G. W. Terman, R. P. Gale & J. C. Liebeskind. 1984. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 223: 188– 190. 58 Rivier, C., J. Rivier & W. Vale. 1986. Stress-induced inhibition of reproductive functions: role of endogenous Corticotropin releasing factor. Science 231: 607– 609. 59 Irwin, M. R., W. Vale & C. Rivier. 1990. Central corticotropin-releasing factor mediates the suppressive effect of stress on natural killer cytotoxicity. Endocrinology 126: 2837– 2844. 60 Vaughn, J., J. Rivier, A. Z. Corrigan, et al. 1989. Detection and purification of inhibin using antisera generated against stythetic peptide fragments. Methods Enzmyol. 168: 588. 61 Jain, R., D. Zwickler, C. S. Hollander, et al. 1991. Corticotropin-releasing factor modulates the immune response to stress in the rat. Endocrinology 128: 1329– 1336. 62 Britton, K. T., G. F. Koob, J. Rivier & W. Vale. 1982. Intracerebroventricular corticotropin-releasing factor enhances the behavioral effects of novelty. Life Sci. 31: 363– 367. 63 Brown, M. R., L. A. Fisher, J. Spiess, C. Rivier, J. Rivier & W. Vale. 1982. Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology 111: 928– 931. 64 Irwin, M. R., W. Vale & K. T. Britton. 1987. Central corticotropin-releasing factor suppresses natural killer cytotoxicity. Brain Behav. Immun. 1: 81– 87. 65 Strausbaugh, H. & M. Irwin. 1992. Central Corticotropin releasing hormone reduces cellular immunity. Brain Behav. Immun. 6: 11– 17. 66 Irwin, M. R., L. Jones, K. Britton & R. L. Hauger. 1989. Central corticotropin releasing factor reduces natural cytotoxicity: time course of action. Neuropsychopharmacology 2: 281– 284. 67 Fleshner, M., L. R. Watkins, L. L. Lockwood, D. Bellgrau, M. L. Laudenslager & S. F. Maier. 1992. Specific changes in lymphocyte subpopulations: a potential mechanism for stress-induced immunomodulation. J. Neuroimmunol. 41: 131– 142. 68 Maier, S. F. & M. L. Laudenslager. 1988. Inescapable shock, shock controllability, and mitogen stimulated lymphocyte proliferation. Brain Behav. Immun. 2: 87– 91. 69 Stenzel-Poore, M. P. & M. B. Rittenberg. 1989. Clonal diversity, somatic mutation, and immune memory to phosphocholine-keyhole limpet hemocyanin. J. Immunol. 143: 4123– 4133. 70 Stenzel-Poore, M. P., U. Bruderer & M. B. Rittenberg. 1988. The adaptive potential of the memory response: clonal recruitment and epitope recognition. Immunol. Rev. 105: 113– 136. 71 Irwin, M. R. 1993. Brain corticotropin-releasing hormone- and interleukin-1 β-induced suppression of specific antibody production. Endocrinology 133: 1352– 1360. 72 Moynihan, J. A., R. Ader, L. J. Grota, T. R. Schachtman & N. Cohen. 1990. The effects of stress on the development of immunological memory following low-dose antigen priming in mice. Brain Behav. Immun. 4: 1– 12. 73 Purkerson, J. & P. Isakson. 1992. A two-signal model for regulation of immunoglobulin isotype switching. FASEB J. 6: 3245– 3252. 74 Okimura, T. & Y. Nigo. 1986. Stress and immune responses. I. Suppression of T cell functions in restraint-stress mice. Jpn. J. Pharmacol. 40: 505– 511. 75 Okimura, T., M. Ogawa & T. Yamauchi. 1986. Stress and immune responses III. Effect of restraint stress on delayed type hypersensitivity (DTH) response, natural killer (NK) activity and phagocytosis in mice. Jpn. J. Pharmacol. 41: 229– 235. 76 Esterling, B. & B. S. Rabin. 1987. Stress-induced alteration of T-lymphocyte subsets and humoral immunity in mice. Behav. Neurosci. 101 (1): 115– 119. 77 Zalcman, S., A. Minkiewicz-Janda, M. Ritchie & H. Anisman. 1988. Critical periods associated with stressor effects on antibody titers and on the plaque-forming cell response to sheep red blood cells. Brain Behav. Immun. 2: 254– 266. 78 NOSSAL, G. J. 1987. Current concepts: immunology the basic components of the immune system. N. Engl. J. Med. 316: 1320– 1326. 79 Heilig, M., M. Irwin, I. Grewal & E. Sercarz. 1993. Sympathetic regulation of T-helper cell function. Brain Behav. Immun. 7: 154– 163. 80 Jiang, C. G., J. L. Morrow-Tesch, D. I. Beller, E. M. Levy & P. H. Black. 1990. Immunosuppression in mice induced by cold water stress. Brain Behav. Immun. 4: 278– 291. 81 Hauger, R. L., M. R. Irwin, M. Lorang, G. Aguilera & M. R. Brown. 1993. High intracerebral levels of CRH result in CRH receptor downregulation in the amygdala and neuroimmune desensitization. Brain Res. 616 (1–2): 283– 292. 82 Smith, E. M., A. C. Morrill, W. J. I. Meyer & J. E. Blalock. 1986. Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 321: 881– 882. 83 Webster, E. L., D. E. Tracey, M. A. Jutila, S. A. J. Wolfe & E. B. De Souza. 1990. Corticotropin-releasing factor receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages. Endocrinology 127: 440– 452. 84 Karalis, K., H. Sano, J. Redwine, S. Listwak, R. L. Wilder & G. P. Chrousos. 1991. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254: 421– 423. 85 Ekman, R., B. Servenius, M. G. Castro, et al. 1993. Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes. J. Neuroimmunol. 44: 7– 14. 86 Stephanou, A., D. S. Jessop, R. A. Knight & S. L. Lightman. 1990. Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes. Brain Behav. Immun. 4: 67– 73. 87 McGillis, J. P., A. Park, P. Rubin-Fletter, C. Turck, M. F. Dallman & D. Payan. 1989. Stimulation of rat B-lymphocyte proliferation by corticotropin releasing factor. J. Neurosci. Res. 23: 346– 352. 88 Singh, V. K. & S.-J. C. Leu. 1993. Corticotropin-releasing factor-induced production of cyclic AMP by human peripheral blood immunocytes. Immunol. Lett. 35: 239– 246. 89 Pawlikowski, M., P. Zelawowski, K. Dohler & H. Stepien. 1992. Effects of two neuropeptides, somatoliberin (GRF) and corticoliberin (CRF) on human lymphocyte natural killer activity. Brain Behav. Immun. 2: 50– 56. 90 Kavelaars, A., F. Berkenbosch, G. Croiset, R. E. Ballieux & C. J. Heijnen. 1990. Induction of β-endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing factor. Endocrinology 126: 759– 764. 91 Kavelaars, A., R. E. Ballieux & C. J. Heijnen. 1990. β-endorphin secretion by human peripheral blood mononuclear cells: regulation by glucocorticoids. Life Sci. 46: 1233– 1240. 92 Heijnen, C. J., A. K. Kavelaars & R. E. Ballieux. 1991. β-Endorphin: cytokine and neuropeptide. Immunol. Rev. 119: 41– 63. 93 Aird, F., C. V. Clevenger, M. B. Prystowsky & E. Redei. 1993. Corticotropin-releasing factor mRNA in rat thymus and spleen. Proc. Natl. Acad. Sci. USA 90: 7104– 7108. 94 Kalin, N. H., S. E. Shelton, C. M. Barksdale & M. S. Brownfield. 1987. A diurnal rhythm in cerebrospinal fluid corticotrophin-releasing hormone different from the rhythm of pituitary-adrenal activity. Brain Res. 426: 385– 391. 95 Saperstein, A., H. Brand, T. Audhya, et al. 1992. Interleukin 1β mediates stressinduced immunosuppression via corticotropin-releasing factor. Endocrinology 130 (1): 152– 158. 96 Munck, A., P. M. Guyre & N. J. Holbrook. 1984. Physiological functions of glucocorticoids in stress and their relation to pharmacologic actions. Endocr. Rev. 5: 25– 44. 97 Irwin, M. R. & R. L. Hauger. 1988. Adaptation to chronic stress: temporal pattern of immune and neuroendocrine correlates. Neuropsychopharmacology 1: 239– 242. 98 Sundar, S. K., M. A. Cierpial, C. Kilts, J. C. Ritchie & J. M. Weiss. 1990. Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor. J. Neurosci. 10 (11): 3701– 3706. 99 Rinner, I. & K. Schauenstein. 1991. The parasympathetic nervous system takes part in the immuno-neuroendocrine dialogue. J. Neuroimmunol. 34: 165– 172. 100 Croiset, G., C. J. Heijnen, W. E. VAN DER Wal, S. F. DE Boer & D. De Wied. 1990. A role for the autonomic nervous system in modulating the immune response during mild emotional stimuli. Life Sci. 46: 419– 425. 101 DEL Rey, A., H. O. Besedovsky, E. Sorkin, M. Da Prada & S. Arrenbrecht. 1981. Immunoregulation mediated by the sympathetic nervous system. II. Cell Immunol. 63: 329– 334. 102 Irwin, M. R., R. Hauger & M. Brown. 1992. Central corticotropin releasing hormone activates the sympathetic nervous system and reduces immune function: increased responsivity of the aged rat. Endocrinology 131 (3): 1047– 1053. 103 Murray, D. R., M. Irwin, C. A. Rearden, M. Ziegler, H. Motulsky & A. S. Maisel. 1992. Sympathetic and immune interactions during dynamic exercise: mediation via beta2-adrenergic dependent mechanism. Circulation 83: 203– 213. 104 Williams, J. M., R. G. Peterson, P. A. Shea, J. F. Schmedtje, D. C. Bauer & D. L. Felten. 1981. Sympathetic innervation of murine thymus and spleen: evidence for a functional link between the nervous and immune systems. Brain Res. Bull. 6: 83– 94. 105 Maisel, A. S., P. Fowler, A. Rearden, H. J. Motulsky & M. C. Michel. 1989. A new method for isolation of human lymphocyte subsets reveals differential regulation of β-adrenergic receptors by terbutaline treatment. Clin. Pharmacol. Ther. 46: 429– 439. 106 Nair, M. P. N. 1993. Effect of neuropeptide Y on natural killer activity of normal human lymphocytes. Brain Behav. Immun. 7: 70– 78. 107 Irwin, M. R., R. L. Hauger, M. Brown & K. T. Britton. 1988. CRF activates autonomic nervous system and reduces natural killer cytotoxicity. Am. J. Physiol. 255: R744– R747. 108 Irwin, M. R., R. L. Hauger, L. Jones, M. Provencio & K. T. Britton. 1990. Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity. J. Pharmacol. Exp. Ther. 255 (1): 101– 107. 109 McCarty, R. 1985. Sympathetic-adrenal medullary and cardiovascular responses to acute cold stress in adult and aged rats. J. Auton. Nerv. Syst. 12: 15– 22. 110 Ershler, W. B., C. L. Coe, S. Gravenstein, et al. 1988. Aging and immunity in nonhuman primates. I. Effects of age and gender on cellular immune function in rhesus monkeys (Macaca mulatta). Am. J. Primatol. 15: 181– 188. 111 Irwin, M. R., M. Brown, T. Patterson, R. Hauger, A. Mascovich & I. Grant. 1991. Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress. FASEB J. 5: 3100– 3107. 112 Makinodan, T. & M. Kay. 1980. Age influence on the immune system. Adv. Immunol. 29: 287– 330. 113 Schleifer, S. J., S. E. Keller, R. N. Bond, J. Cohen & M. Stein. 1989. Major depressive disorder and immunity: role of age, sex, severity, and hospitalization. Arch. Gen. Psychiatry 46: 81– 87. 114 Ackerman, K. D., D. L. Bellinger, S. Y. Felten & D. L. Fèlten. 1991. Ontogeny and senescence of noradrenergic innervation of the rodent thymus and spleen. In Psychoneuroimmunology. R. Ader, D. L. Felten & N. Cohen, Eds.: 72– 115. Academic Press. San Diego , CA . 115 Hellstrand, K., S. Hermodsson & O. Strannegård. 1985. Evidence for a β-adrenoceptor-mediated regulation of human natural killer cells. J. Immunol. 134: 4095– 4099. 116 Zalcman, S., J. Irwin & H. Anisman. 1991. Stressor-induced alterations of natural killer cell activity and central catecholamines in mice. Pharmacol. Biochem. Behav. 39: 361– 366. 117 De Blasi, A., M. Lipartiti, S. Algeri, et al. 1986. Stress induced desensitization of lymphocyte β-adrenoceptors in young and aged rats. Pharmacol. Biochem. Behav. 24: 991– 998. 118 Sapolsky, R. M., L. C. Krey & B. S. McEwen. 1986. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev. 7 (3): 284– 300. 119 Ono, N., J. C. B. De Castro & S. M. McCann. 1985. Ultrashort-loop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH in stress. Proc. Natl. Acad. Sci. USA 82: 3528– 3531. 120 Nem̊eroff, C. B., M. J. Owens, G. Bisette & M. Stanley. 1988. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch. Gen. Psychiatry 45: 577– 582. 121 Herbert, T. B. & S. Cohen. 1993. Depression and immunity-a meta-analytic review. Psych. Bull. 113: 472– 486. 122 Romano, T. A., S. Y. Felten, D. L. Felten & J. A. Olschowka. 1991. Neuropeptide-Y innervation of the rat spleen: another potential immunodulatory neuropeptide. Brain Behav. Immun. 5: 116– 131. 123 Maes, M., E. Bosmans, E. Suy, B. Minner & J. Raus. 1989. Impaired lymphocyte stimulation by mitogens in severely depressed patients a complex interface with HPA axis hyperfunction, noradrenergic activity and the ageing process. Br. J. Psychiatry 155: 793– 798. 124 Glaser, R., J. K. Kiecolt-Glaser, R. H. Bonneau, W. Malarkey, S. Kennedy & J. Hughes. 1992. Stress-induced modulation of the immune response to recombinant hepatitis B vaccine. Psychosom. Med. 54: 22– 29. 125 Sternberg, E. M., W. S. Young, III, A. E. Calogero, et al. 1989. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. USA 86: 4771– 4775. Citing Literature Volume771, Issue1Stress: Basic Mechanisms and Clinical ImplicationsDecember 1995Pages 396-418 ReferencesRelatedInformation